Safety Alert for Sarns™ Antegrade Cardioplegia Cannula

According to Department of Health, this safety alert involved a device in Hong Kong that was produced by Terumo CVS Corporation.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2012-05-14
  • Event Date Posted
    2012-05-14
  • Event Country
  • Event Source
    DH
  • Event Source URL
  • Notes / Alerts
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Extra notes in the data
    Medical Device Safety Alert
  • Reason
    Medical device safety alert: terumo sarns™ antegrade cardioplegia cannula medical device manufacturer, terumo cvs corporation, has issued an urgent field safety notice concerning sarns™ antegrade cardioplegia cannula. the manufacturer is recalling certain lots of the devices as they found a foreign substance on the inner surface of some cannulae tips. their preliminary investigation revealed that the substance can be dislodged from the cannula surface. moreover, the substance was likely deposited during the molding process, but the exact composition of the substance is still undetermined; and any unit manufactured within the last three years on the same mold could potentially be affected. the resulting patient harm would vary from a localized inflammatory response in the coronary vasculature that could result in post-operative myocardial irritability to the creation of an embolus that would disrupt or block coronary blood flow and could result in post-operative myocardial infarction. if particulate escaped the coronary arteries and embolized elsewhere in the vasculature, the results could vary from a localized inflammatory response to organ dysfunction or stroke. there have been no reports of patient injury related to this issue. according to the local supplier, the affected devices were not distributed in hong kong. if you are in possession of the affected product, please contact your supplier for necessary actions. posted on 14 may 2012.

Device

  • Model / Serial
  • Product Description
    Medical Device Safety Alert: Terumo Sarns™ Antegrade Cardioplegia Cannula
  • Manufacturer

Manufacturer